CAMBRIDGE, Mass., Dec. 10, 2025 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. ® (“Fulcrum”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced the pricing of its previously announced underwritten public offering of 11,851,853 shares of its common stock at a public offering price of $13.50 per share, and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 1,111,193 shares of common stock at a public offering price of $13.499 per pre-funded warrant, which represents the per share public offering price of each share of common stock less the $0.001 per share exercise price of each pre-funded warrant. The gross proceeds to Fulcrum from the offering, before deducting underwriting...

Performance dividend of Cdn$0.05 per Share Declared1Total dividends declared in 2025 surge to Cdn$0.18 per ShareAmerigo’s Capital Return Strategy Fully Deployed in 2025 including 3.97 million shares retiredVANCOUVER, British Columbia, Dec. 10, 2025 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is pleased to announce that on December 9, 2025, Amerigo’s Board of Directors declared a performance dividend in the amount of Cdn$0.05 per share, payable on January 15, 2026, to shareholders of record as of December 17, 20251. Amerigo designates the entire amount of this taxable dividend to be an “eligible dividend” for purposes of the Income Tax Act (Canada), as amended from time to time. “We are very pleased to declare this performance dividend. A performance dividend underscores...

TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd. (TSXV: QGR; OTCQB: QGLDF; Börse Frankfurt: QX9G) (“QGold” or the “Company”) is pleased to announce that it will be hosting a corporate update presentation with analysts and investors via live webinar on Wednesday, December 10, 2025, at 10:30 a.m. EST. Participants can register to attend at the following web address: https://us02web.zoom.us/meeting/register/kp-TbwUIT7-La5-KUfARow. Specifically, the webinar will feature QGold’s Chief Executive Officer, Peter Tagliamonte, to discuss updates on the Company’s business developments. The Company also announced today that it has granted an aggregate amount of 500,000 stock options to a director and officer pursuant to its stock option plan. The options vest immediately, are subject to a four-month hold period from the date...

COLUMBUS, Ohio, Dec. 10, 2025 (GLOBE NEWSWIRE) — Bread Financial Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending, and saving solutions to millions of U.S. consumers, provided a performance update. The following tables present the Company’s net loss rate and delinquency rate for the periods indicated:         For themonth endedNovember 30, 2025   For themonth endedNovember 30, 2024  (dollars in millions)End-of-period credit card and other loans $ 18,094     $ 18,143  Average credit card and other loans $ 17,776     $ 17,947  Year-over-year change in average credit card and other loans   (1 %)     (1 %)Net principal losses(1) $ 109     $ 118  Net loss rate(1)   7.4 %     8.0 %                        As ofNovember 30, 2025   As...

WASHINGTON, Dec. 10, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Mitch Harris as a Senior Managing Director in the Healthcare Risk Management & Advisory practice within the firm’s Forensic and Litigation Consulting segment. Mr. Harris, who is based in Los Angeles, has more than three decades of experience driving healthcare strategy for major health plans, health systems and pharmacy benefit managers across the United States. His expertise includes leveraging data and AI to improve performance and support clients with operational and regulatory challenges. In his role at FTI Consulting, he will support clients with regulatory strategy and government programs compliance, as well as operational optimization and turnaround initiatives. “The healthcare industry is experiencing...

Independent review by Black & Veatch affirms Stardust Power’s Muskogee lithium refinery meets industry standards The independent review delivered the following key findings:Low technical and design risk. Phase 1 production targets deemed achievable.GREENWICH, Conn., Dec. 10, 2025 (GLOBE NEWSWIRE) — Stardust Power Inc. (NASDAQ: SDST) (“Stardust Power” or the “Company”), an American developer of battery-grade lithium carbonate, today announced the completion of an independent third-party review of its Front-End Loading 3 (“FEL 3”) engineering study for its lithium carbonate refinery project in Muskogee, Oklahoma. Stardust Power engaged Black & Veatch, a global engineering, construction and consulting company providing infrastructure solutions to clients around the world, to conduct a rigorous Independent Engineering...

BriaCell presents positive clinical data in three posters at the San Antonio Breast Cancer Symposium (SABCS®) Phase 3 study of Bria-IMT™ plus immune check point inhibitor (CPI) continues to support biomarkers to identify patients who benefit from treatment with BriaCell’s regimen Maturing Phase 2 study data continues to support meaningful clinical benefit of the Bria-IMT regimen with outstanding long-term survival No toxicity related discontinuations in Phase 3PHILADELPHIA and VANCOUVER, British Columbia, Dec. 10, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, presents positive Phase 2 survival, and Phase 3 biomarker data across three clinical posters...

Operating Profit of $22 million, up 36.7% YoY, Operating Margin of 9.4% Double-digit growth in orders and sales Entering Second Half with $321 million of Product Backlog, up 36% from second quarter fiscal 2025 Ending Net Cash Balance of $138 million Business and Digital Transformation on Track; Reiterating Three Year Forward Objectives of 7-10% Sales Growth, 10-12% operating margin, 17-20% ROIC BROOKINGS, S.D., Dec. 10, 2025 (GLOBE NEWSWIRE) — Daktronics, Inc. (NASDAQ-DAKT) (the “Company”, “Daktronics”, “we”, or “us”), a recognized industry leader in the design and manufacturing of best-in-class dynamic video communication displays and control systems for customers worldwide, today reported results for its fiscal 2026 second quarter which ended November 1, 2025. Fiscal 2026 is a 53-week year and fiscal 2025 was a 52-week year....

Dragonfly Energy announces distribution partnership with National Railway Supply LLC (“NRS”), marking the first lithium battery line offered by the long-standing rail supplier. AREMA formally approves its first lithium battery standard, creating a clear framework for LiFePO₄ adoption; Dragonfly Energy contributed to the multi-year development process and adoption. NRS to feature Battle Born Batteries® at the AREMA Communication Signals and Information Technology Symposium in March 2026, where Dragonfly Energy CEO Dr. Denis Phares will also present on LiFePO₄ technology and standards.RENO, Nev., Dec. 10, 2025 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker of Battle Born Batteries®, announced a new distribution partnership...